Enhancing Molecular Testing for Metastatic Colorectal Cancer Patients
Pfizer Canada and Colorectal Cancer Canada
The intent of this RFP is to encourage the applicant Canadian organizations and institutions to pursue innovative approaches for quality improvement projects that aim to develop or optimize molecular testing for patients in metastatic CRC at the applicants’ centre. Applicants are invited to implement innovative ideas with the goal of creating a path for sustainable molecular testing for cancer patients in Canada.
Individual projects requesting up to a maximum of $100,000 (CAD) will be considered. The total available budget related to this RFP is $300,000 (CAD).
Deadlines
| UM Internal Deadline | Sponsor Deadline | |
|---|---|---|
Application | 30-Apr-2024 4:30 pm CST | 09-May-2024 11:59 pm EST |
Important
The information in this directory is provided as a service to the University Community and anyone with legitimate business with the University. Use of this directory to prepare mass mailings is prohibited.